Application of CRISPR/Cas for Diagnosis and Management of Viral Diseases of Banana

被引:31
|
作者
Tripathi, Leena [1 ]
Ntui, Valentine Otang [1 ]
Tripathi, Jaindra Nath [1 ]
Kumar, P. Lava [2 ]
机构
[1] Int Inst Trop Agr, Nairobi, Kenya
[2] Int Inst Trop Agr, Ibadan, Nigeria
关键词
banana; viral diseases; BBTV; BSV; genome editing; CRISPR; Cas; diagnosis; disease-resistance; BUNCHY-TOP-VIRUS; INHIBIT HIV-1 REPLICATION; NUCLEIC-ACID DETECTION; GENOME; RESISTANCE; EXPRESSION; GENE; MICROPROPAGATION; CONTAINS; PROTEINS;
D O I
10.3389/fmicb.2020.609784
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Viral diseases are significant biotic constraints for banana (Musa spp.) production as they affect the yield and limit the international movement of germplasm. Among all the viruses known to infect banana, the banana bunchy top virus and banana streak viruses are widespread and economically damaging. The use of virus-resistant bananas is the most cost-effective option to minimize the negative impacts of viral-diseases on banana production. CRISPR/Cas-based genome editing is emerging as the most powerful tool for developing virus-resistant crop varieties in several crops, including the banana. The availability of a vigorous genetic transformation and regeneration system and a well-annotated whole-genome sequence of banana makes it a compelling candidate for genome editing. A robust CRISPR/Cas9-based genome editing of the banana has recently been established, which can be applied in developing disease-resistant varieties. Recently, the CRISPR system was exploited to detect target gene sequences using Cas9, Cas12, Cas13, and Cas14 enzymes, thereby unveiling the use of this technology for virus diagnosis. This article presents a synopsis of recent advancements and perspectives on the application of CRISPR/Cas-based genome editing for diagnosing and developing resistance against banana viruses and challenges in genome-editing of banana.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Application of CRISPR Cas Systems for Biosensing
    Liu, Chung Chiun
    Dai, Yifan
    BIOSENSORS-BASEL, 2023, 13 (07):
  • [32] Potential of the CRISPR-Cas system for improved parasite diagnosis CRISPR-Cas mediated diagnosis in parasitic infections
    You, Hong
    Gordon, Catherine A.
    MacGregor, Skye R.
    Cai, Pengfei
    McManus, Donald P.
    BIOESSAYS, 2022, 44 (04)
  • [33] Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines
    Tang, Na
    Zhang, Yaoyao
    Shen, Zhiqiang
    Yao, Yongxiu
    Nair, Venugopal
    CRISPR JOURNAL, 2021, 4 (04): : 477 - 490
  • [34] Role and application of CRISPR-Cas9 in the management of Alzheimer's disease
    Soni, Nilay
    Kar, Indrani
    Narendrasinh, Jadav Dhruvkumar
    Shah, Sanjay Kumar
    Konathala, Lohini
    Mohamed, Nadine
    Kachhadia, Meet Popatbhai
    Chaudhary, Mitul Hareshkumar
    Dave, Vyapti A.
    Kumar, Lakshya
    Ahmadi, Leeda
    Golla, Varshitha
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (03): : 1517 - 1521
  • [35] Application and development of CRISPR-Cas12a methods for the molecular diagnosis of cancer: A review
    Wang, Sidan
    Shen, Xiaoyu
    Chen, Guanxiao
    Zhang, Wei
    Tan, Buzhen
    ANALYTICA CHIMICA ACTA, 2025, 1341
  • [36] Development and application of sensitive, specific, and rapid CRISPR-Cas13-based diagnosis
    Shihong Gao, David
    Zhu, Xiaodong
    Lu, Binfeng
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4198 - 4204
  • [37] Control of Plant Viral Diseases by CRISPR/Cas9: Resistance Mechanisms, Strategies and Challenges in Food Crops
    Shahriar, Saleh Ahmed
    Islam, M. Nazrul
    Chun, Charles Ng Wai
    Rahim, Md Abdur
    Paul, Narayan Chandra
    Uddain, Jasim
    Siddiquee, Shafiquzzaman
    PLANTS-BASEL, 2021, 10 (07):
  • [38] Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases
    Joshua Kuruvilla
    Andrew Octavian Sasmita
    Anna Pick Kiong Ling
    Neurological Sciences, 2018, 39 : 1827 - 1835
  • [39] Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases
    Kuruvilla, Joshua
    Sasmita, Andrew Octavian
    Ling, Anna Pick Kiong
    NEUROLOGICAL SCIENCES, 2018, 39 (11) : 1827 - 1835
  • [40] CRISPR/Cas9 in allergic and immunologic diseases
    Goodman, Michael A.
    Manesh, Donya Moradi
    Malik, Punam
    Rothenberg, Marc E.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (01) : 5 - 9